Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-021160·BiomX Inc.
Schedule 13G ownership disclosure
BIOMX INC
Common Stock, $0.0001 par value per share · CUSIP: 09090D103
Event date: 2024-09-30
- Filing-level shares
- 4,094,558
- Percent of class
- 19.99%
- Cystic Fibrosis Foundation
Shares: 4,094,558 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021160
- Form type
- SCHEDULE 13G/A
- Filer
- BiomX Inc.
- CIK
- CIK 1739174
- Filed
- Feb 14, 2025
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership